WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION
(Adnkronos) – SUNNYVALE, Calif., Oct. 3, 2023 /PRNewswire/ — Willow Biosciences Inc., (“Willow”) (TSX: WLLW) (OTCQB: CANSF) and SUANFARMA today jointly announced execution of a collaboration agreement for a cell line productivity optimization development
